Zbtb44介导的转录抑制关键调控结肠炎症
Zbtb44-mediated transcriptional repression critically regulates colonic inflammation
Zbtb44介导的转录抑制关键调控结肠炎症,相关研究发表于 Nature Immunology。研究数据包括 RNA-seq(GEO GSE294267)、CUT&RUN(GEO GSE330990)及 16S rRNA 测序(NCBI SRA PRJNA1514237),均已提供获取信息。
Data availability
All data supporting the findings are available within the article and supplementary materials or from the corresponding author upon request. RNA-seq data are available under GEO accession number GSE294267 and CUT&RUN data are available under GEO accession number GSE330990. The 16S rRNA sequencing raw data supporting the results of this article are available from the Sequence Read Archive, with project ID: PRJNA1514237 in the NCBI. Source data are provided with this paper.
References
Strober, W., Fuss, I. J. & Blumberg, R. S. The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 20, 495–549 (2002).
Neurath, M. F. Cytokines in inflammatory bowel disease. Nat. Rev. Immunol. 14, 329–342 (2014).
Ivashkiv, L. B. IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat. Rev. Immunol. 18, 545–558 (2018).
Wang, F. et al. IFN-γ-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction. Gastroenterology 131, 1153–1163 (2006).
Walrath, T. et al. IFN-γ and IL-17A regulate intestinal crypt production of CXCL10 in the healthy and inflamed colon. Am. J. Physiol. Gastrointest. Liver Physiol. 318, G479–G489 (2020).
Kamada, N. et al. Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-γ axis. J. Clin. Invest. 118, 2269–2280 (2008).
Neurath, M. F. Strategies for targeting cytokines in inflammatory bowel disease. Nat. Rev. Immunol. 24, 559–576 (2024).
Lee, S. U. & Maeda, T. POK/ZBTB proteins: an emerging family of proteins that regulate lymphoid development and function. Immunol. Rev. 247, 107–119 (2012).
Cheng, Z. Y., He, T. T., Gao, X. M., Zhao, Y. & Wang, J. ZBTB transcription factors: key regulators of the development, differentiation and effector function of T cells. Front. Immunol. 12, 713294 (2021).
Maeda, T. Regulation of hematopoietic development by ZBTB transcription factors. Int. J. Hematol. 104, 310–323 (2016).
Punwani, D. et al. Transcription factor zinc finger and BTB domain 1 is essential for lymphocyte development. J. Immunol. 189, 1253–1264 (2012).
Siggs, O. M., Li, X., Xia, Y. & Beutler, B. ZBTB1 is a determinant of lymphoid development. J. Exp. Med. 209, 19–27 (2012).
Saba, I., Kosan, C., Vassen, L. & Moroy, T. IL-7R-dependent survival and differentiation of early T-lineage progenitors is regulated by the BTB/POZ domain transcription factor Miz-1. Blood 117, 3370–3381 (2011).
Kosan, C. et al. Transcription factor miz-1 is required to regulate interleukin-7 receptor signaling at early commitment stages of B cell differentiation. Immunity 33, 917–928 (2010).
Muroi, S. et al. Cascading suppression of transcriptional silencers by ThPOK seals helper T cell fate. Nat. Immunol. 9, 1113–1121 (2008).
Potter, D. W. & Djuric, Z. Comparison of 8-hydroxydeoxyguanosine and 5-hydroxymethyluracil as products of oxidative DNA damage. Adv. Exp. Med. Biol. 283, 801–803 (1991).
Johnston, R. J. et al. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 325, 1006–1010 (2009).
Nurieva, R. I. et al. Bcl6 mediates the development of T follicular helper cells. Science 325, 1001–1005 (2009).
Yu, D. et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity 31, 457–468 (2009).
Pernat Drobez, C. et al. DNA polymorphisms predict time to progression from uncomplicated to complicated Crohn’s disease. Eur. J. Gastroenterol. Hepatol. 30, 447–455 (2018).
Zhou, X. et al. ZBTB44-FLT3 fusion in a patient with a myeloproliferative neoplasm. Br. J. Haematol. 191, 297–301 (2020).
Iliev, I. D., Ananthakrishnan, A. N. & Guo, C. J. Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities. Nat. Rev. Microbiol. 23, 509–524 (2025).
Kathania, M. et al. Itch inhibits IL-17-mediated colon inflammation and tumorigenesis by ROR-γt ubiquitination. Nat. Immunol. 17, 997–1004 (2016).
Casanova, J. L., MacMicking, J. D. & Nathan, C. F. Interferon-γ and infectious diseases: lessons and prospects. Science 384, eadl2016 (2024).
Kumar, R., Theiss, A. L. & Venuprasad, K. RORγt protein modifications and IL-17-mediated inflammation. Trends Immunol. 42, 1037–1050 (2021).
Bailey, S. R. et al. Human CD26highT cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence. Nat. Commun. 8, 1961 (2017).
Szabo, S. J. et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 655–669 (2000).
Rauluseviciute, I. et al. JASPAR 2024: 20th anniversary of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 52, D174–D182 (2024).
Concordet, J. P. & Haeussler, M. CRISPOR: intuitive guide selection for CRISPR–Cas9 genome editing experiments and screens. Nucleic Acids Res. 46, W242–W245 (2018).
Garrido-Trigo, A. et al. Macrophage and neutrophil heterogeneity at single-cell spatial resolution in human inflammatory bowel disease. Nat. Commun. 14, 4506 (2023).
Uzzan, M. et al. Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity. Nat. Med. 28, 766–779 (2022).
Cui, K. et al. Restraint of IFN-γ expression through a distal silencer CNS-28 for tissue homeostasis. Immunity 56, 944–958 e946 (2023).
Vertegaal, A. C. O. Signalling mechanisms and cellular functions of SUMO. Nat. Rev. Mol. Cell Biol. 23, 715–731 (2022).
Perry, J. J., Tainer, J. A. & Boddy, M. N. A SIM-ultaneous role for SUMO and ubiquitin. Trends Biochem. Sci. 33, 201–208 (2008).
Geiss-Friedlander, R. & Melchior, F. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 8, 947–956 (2007).
Gareau, J. R. & Lima, C. D. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat. Rev. Mol. Cell Biol. 11, 861–871 (2010).
Song, J., Durrin, L. K., Wilkinson, T. A., Krontiris, T. G. & Chen, Y. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proc. Natl Acad. Sci. USA 101, 14373–14378 (2004).
Hecker, C. M., Rabiller, M., Haglund, K., Bayer, P. & Dikic, I. Specification of SUMO1- and SUMO2-interacting motifs. J. Biol. Chem. 281, 16117–16127 (2006).
Minty, A., Dumont, X., Kaghad, M. & Caput, D. Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif. J. Biol. Chem. 275, 36316–36323 (2000).
Jardin, C., Horn, A. H. & Sticht, H. Binding properties of SUMO-interacting motifs (SIMs) in yeast. J. Mol. Model. 21, 50 (2015).
Zhao, Q. et al. GPS-SUMO: a tool for the prediction of sumoylation sites and SUMO-interaction motifs. Nucleic Acids Res. 42, W325–W330 (2014).
Kang, S. I., Chang, W. J., Cho, S. G. & Kim, I. Y. Modification of promyelocytic leukemia zinc finger protein (PLZF) by SUMO-1 conjugation regulates its transcriptional repressor activity. J. Biol. Chem. 278, 51479–51483 (2003).
Bereshchenko, O. R., Gu, W. & Dalla-Favera, R. Acetylation inactivates the transcriptional repressor BCL6. Nat. Genet. 32, 606–613 (2002).
Brustle, A. et al. The development of inflammatory TH-17 cells requires interferon-regulatory factor 4. Nat. Immunol. 8, 958–966 (2007).
El-Behi, M. et al. The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 12, 568–575 (2011).
Kumar, R., Theiss, A. T. & Venuprasad, K. RORγt protein modifications in IL-17-mediated inflamamtion. Trends Immunol. 42, 1037–1050 (2021).
Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).
Acknowledgements
We thank all current and past members of the Poojary Lab for their contributions.
Funding
This work was supported by NIH grants (R01-AI155786, R01-CA266072 and R01-CA282143) and translational pilot project grants from the Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center to K.V.
Author information
Authors and Affiliations
Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA
Mahesh Kathania, Desh Raj, Thirupugal Govindarajan, Amit K. Verma, Anirban Roy, Risha Mathur, Jenna Woody, Amir Kumar Singh, Suraj Patel, Jianyi Yin, Ezra Burstein & K. Venuprasad
Department of Immunology, UT Southwestern Medical Center, Dallas, TX, USA
Mahesh Kathania, Desh Raj, Thirupugal Govindarajan, Amit K. Verma, Anirban Roy, Risha Mathur, Jenna Woody, Amir Kumar Singh, Tuoqi Wu & K. Venuprasad
Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA
Mahesh Kathania, Desh Raj, Thirupugal Govindarajan, Amit K. Verma, Anirban Roy, Risha Mathur, Jenna Woody, Amir Kumar Singh, Chul Ahn, Tuoqi Wu & K. Venuprasad
Eugene McDermott Center for Human Growth and Development, The University of Texas Southwestern Medical Center, Dallas, TX, USA
Dinesh Ravindra Raju & Chao Xing
Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX, USA
Andrew Lemoff
Division of Gastroenterology and Hepatology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA
Arianne L. Theiss
Lyda Hill Department of Bioinformatics, The University of Texas Southwestern Medical Center, Dallas, TX, USA
Chao Xing
Peter O’Donnell School of Public Health, The University of Texas Southwestern Medical Center, Dallas, TX, USA
Chao Xing
Authors
- Mahesh Kathania
- Desh Raj
- Thirupugal Govindarajan
- Dinesh Ravindra Raju
- Amit K. Verma
- Anirban Roy
- Risha Mathur
- Jenna Woody
- Amir Kumar Singh
- Chul Ahn
- Suraj Patel
- Jianyi Yin
- Andrew Lemoff
- Arianne L. Theiss
- Chao Xing
- Tuoqi Wu
- Ezra Burstein
- K. Venuprasad
Contributions
K.V., D.R. and M.K. conceived the study and wrote the manuscript. M.K., D.R, T.G., D.R.R., A.R., A.K.V., R.M., J.Y., C.A., J.W. and A.K.S. performed experiments and data analysis. A.L. conducted mass spectrometry analysis. A.L.T. and S.P. contributed to manuscript preparation. C.X. assisted in statistical analysis. T.W. assisted with LCMV experiments. E.B. and J.Y. assisted with human biopsy experiments.
Corresponding author
Correspondence to K. Venuprasad.
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Immunology thanks the anonymous reviewer(s) for their contribution to the peer review of this work. Primary Handling Editor: L. A. Dempsey, in collaboration with the Nature Immunology team.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Normal T cell development in 7-10-week-old Zbtb44 − /− mice and Zbtb44 + /− mice does not exhibit spontaneous colitis.
a, Representative images of spleen and lymph nodes from Zbtb44+/+ and Zbtb44−/− mice. b, Gating strategy for flow cytometry. c-d, Cells from the thymus, spleen, and lymph nodes were stained with antibodies against CD4, CD8, CD3, CD25, and FoxP3 and analyzed by flow cytometry. (n = 3 biologically independent samples per group). e, Representative H&E-stained sections of Zbtb44+/+ and Zbtb44+/− mice. Scale bars, 100 μm.
Extended Data Fig. 2 Microbiota composition in young and old Zbtb44−/− mice and Co-housing does not transfer colitis phenotype.
16S rRNA sequencing of fecal pellets from young and aged Zbtb44+/+ and Zbtb44−/− mice showing: a, d, Relative abundance of phylum-level microbiota. b, e, Beta diversity. c, f, Alpha diversity. g, Representative H&E images of Zbtb44+/+ mice and Zbtb44+/+ mice co-housed with Zbtb44−/− mice. (n = 3 biologically independent samples per group). Scale bars, 100 μm.
Extended Data Fig. 3 Increased IFN-γ production in Zbtb44−/− mice following LCMV infection.
Zbtb44+/+ and Zbtb44−/− mice were infected with LCMV clone 13 for 7 days. a, Viral titers (FFU) in spleen. b-d, Splenocytes were analyzed by CyTOF. b, Heatmaps of cell clusters. c, Representative cell populations. d, IFN-γ-producing CD4+, CD8+, and T-bet+ cells. e-j, Flow cytometry showing IFN-γ production in CD4+, CD8+, γδT, NKT, and NK cells. (k-l) Flow cytometry analysis of CD4+ and CD8+ T cells from mice that are infected with Armstrong strain of LCMV. Statistical significance in a was determined by two-sided unpaired Student’s t-test. Data are mean ± s.d. ***P < 0.001.
Extended Data Fig. 4 IFN-γ expression in Th17, Th2 and Treg cells, increased inflammatory gene expression in DSS-treated Zbtb44−/− mice.
a-c, qPCR analysis of IFN-γ in Th17, Th2 and Treg cells. d-h, qPCR analysis of Il-22, Csf1/2, Il23a, and Il17 in cLPLs. Statistical significance in a was determined by two-sided unpaired Student’s t-test. Data are mean ± s.d. ***P < 0.001; ****P < 0.0001.
Extended Data Fig. 5 Elevated IFN-γ without changes in polyfunctional CD4+ T cells or NK differentiation.
a, Spleen, MLN, and cLPLs from DSS-treated mice stained for CD4, IL-17A, and IFN-γ. b, solenocytes of aged Zbtb44+/+ and Zbtb44−/− mice stained for CD4, IL-17A, and IFN-γ. c, NK cell subsets were analyzed using NK1.1, CD11b, and CD27. d, Splenocytes stained for CD4 and CD26 (polyfunctional T cells).
Extended Data Fig. 6 IFN-γ expression after sgRNA blocking of Zbtb44 binding site at Ifng locus and expression Zbtb44 in CD8+ T cells and T cells from ulcerative colitis patients.
a-b, CRISPR interference targeting Zbtb44-binding sites in CD4+ T cells and analysis of Ifng expression by qPCR. c, ChIP analysis of Zbtb44 binding in sgRNA-treated CD4+ T cells.d, Protein expression was measured by Western blot following CD3 + CD28 activation, Single-cell RNA-seq analysis of colon biopsies showing Zbtb44 expression in e, CD8+ T cells, f, NCAM1+ NK cells, and g, CD3−NCAM1+ NK cells. Statistical significance in b was determined by one-way ANOVA followed by Bonferroni correction for multiple comparisons. Data are mean ± s.d. ***P < 0.001.
Extended Data Fig. 7 Epigenetic regulation of T-bet target genes.
a, RNA-seq tracks of Ifng expression in Zbtb44+/+ and Zbtb44−/− cells. b. CUT&RUN tracks of Zbtb44 biding at Ccl3 promoter with green marks showing Zbtb44 peak (peak 5120, q = 6.67E-03) and H3K4me3 peak at promoter (KO peak 3905, q = 3.43E-25). c. CUT&RUN tracks at the Ccl4 promoter with green marks show Zbtb44 peak (peak 5122, q = 1.07E-04) and H3K4me3 peak (KO peak 3906, q = 9.07E-59). d. CUT&RUN tracks at Irf4 promoter with green marks showing Zbtb44 peak (peak 7639, q = 3.75E-04), H3K4me3 peak (KO peak 6058, q < 1.00E-300). e. Zbtb44 tracks at Tcf7 promoter. f. Zbtb44 tracks at Cxcr3 promoter. g. Zbtb44, H3K4me3, H3K27ac at Il2 promoter. h. Gzmb promoter. i. Gzmd promoter. j. Il23a promoter. k. Csf2: Zbtb44 peak (peak 4443, q = 1.66E-06). l. Il17a: Zbtb44 peak (peak 106, q = 2.40E-02), with, m. H3K4me3 and H3K27ac at Il17a promoter. Peaks called with MACS3 at q < 0.05.
Extended Data Fig. 8 Zbtb44-T-bet interaction is SUMOylation-dependent and expression of T-bet-dependent genes.
a-c, Co-immunoprecipitation assays in 293 T cells. d, IFN-γ ELISA from CD4+ T cells expressing indicated constructs. e-g, qPCR of T-bet-dependent genes following transduction. Statistical significance in d-g was determined by one-way ANOVA followed by Bonferroni correction for multiple comparisons. Data are mean ± s.d ***P < 0.001, ****P < 0.0001.
Extended Data Fig. 9 Zbtb44−/− phenotype is requires T cells and severe colitis in Zbtb44−/− mice requires IFN-γ (adoptive transfer model).
a, H&E sections of Zbtb44+/+, Zbtb44−/−, Rag−/−, and Zbtb44−/−Rag−/− mice. b, Body weight measurements. CD4+CD25−CD45RBhi cells were transferred into Rag−/− mice. c, Colon weight-to-length ratio. d, Diarrhea score. (n = 5 biologically independent samples per group). Scale bars, 100 μm. Statistical significance in b-d was determined by one-way ANOVA followed by Bonferroni correction for multiple comparisons. Data are mean ± s.d. ***P < 0.001, ****P < 0.0001.
Extended Data Fig. 10 IFN-γ is required for severe DSS-induced colitis in Zbtb44−/− mice.
a, Body weight change. b, Colon morphology. c, Colonoscopy images. d, IFN-γ ELISA. e, H&E staining. f-g, Fecal occult blood and diarrhea score. h, qPCR analysis of Ifng from cLPLs. (n = 5 biologically independent samples per group). Scale bars, 100 μm. Statistical significance in a,d and f-h was determined by one-way ANOVA followed by Bonferroni correction for multiple comparisons. Data are mean ± s.d. **P < 0.01; ***P < 0.001; ****P < 0.0001.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kathania, M., Raj, D., Govindarajan, T. et al. Zbtb44-mediated transcriptional repression critically regulates colonic inflammation. Nat Immunol (2026). https://doi.org/10.1038/s41590-026-02675-4
Received: 01 April 2025
Accepted: 02 September 2026
Published: 12 October 2026
Version of record: 12 October 2026
DOI: https://doi.org/10.1038/s41590-026-02675-4
来源:Nature Immunology · nature.com